drugset
drugset / Trial / NCT04258865

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

NCT04258865 ↗

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare the pharmacokinetics and tolerability of CKD-348

Timeline

Start
2020-03-25
Primary completion
2020-04-26
Completion
2020-05-13

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348 Unknown — Oral
Subject CKD-828 Unknown — Oral
Subject D097 Unknown — Oral
Subject D337 Unknown — Oral

Indications

hyperlipidemia hypertensive disorder